Finally, the MEOX2-GLI1 axis was validated by investigating the proliferation capacity of the A549 and NH2347 lung cancer cell lines in clonogenic assays, and we identified statistically significant differences (p≤0.01, and p≤0.001) compared with H1975 lung cancer cells (Figure 7C). This evidence concerns the gene MEOX2 and lung carcinoma.